Please login to the form below
NAO
This page shows the latest NAO news and features for those working in and with pharma, biotech and healthcare.
NHS reliance on ‘short-term measures’ has made it financially unstable, auditors report
The findings come from a report made by the National Audit Office (NAO), which looked at the financial stability of the NHS. ... This contributed to a backlog of maintenance work of around £6.5bn, according to NAO.
Latest news
-
Significant gaps remain in UK’s no-deal Brexit prep, says NAO report
With just 34 days until the UK is scheduled to leave the EU, the National Audit Office (NAO) says there is still a significant amount of work to do to avoid ... Among the concerns presented by the NAO is that the government has an incomplete picture of
-
Warning ‘at red’ on no deal Brexit medicines chaos
Time has already run out for the UK to prepare for a no deal Brexit, according to a National Audit Office (NAO) report which says that key physical and IT infrastructure ... The coalition of healthcare stakeholders wrote to Hancock yesterday, alarmed by
-
Daily Brief: Health and social care still divided, Opdivo rejected in bladder cancer, Xalkori extends reach
The National Audit Office (NAO) has today published a report assessing the challenges preventing health and social care from working together effectively, and says it wants to encourage the government to ... Serious political leadership is needed.”.
-
National Audit Office agrees CDF is 'unsustainable'
Says a replacement for the CDF is urgently needed. The UK's National Audit Office (NAO) has put an official seal on what has been generally known - the Cancer Drugs Fund ... starting to impact on funding available for other health services - an
-
Key cancer area improvement in England
The recent NAO report said achievements have been made for waiting times associated with treatment and support, with reductions also made in the time spent in hospital. ... With its report, the NAO suggest efficiency methods, including reducing the
More from news
Approximately 2 fully matching, plus 12 partially matching documents found.
Latest Intelligence
-
Seeking improvements
Reports from The King's Fund and National Audit Office (NAO) pointed to serious shortcomings in service provision in NHS England and concluded that, although much work was taking place to ... key recommendations contained in the King's Fund and NAO
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Eli Lilly’s Alzheimer’s drug denied FDA accelerated approval
- EU outlines measures to mitigate antibiotic shortage across Europe
- Europe’s cancer community publishes new report on transforming patient care
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Takeda’s all-oral multiple myeloma triplet therapy recommended by NICE
- Why everyone in pharma is bending over backwards to be agile
- Eli Lilly’s Alzheimer’s drug denied FDA accelerated approval
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
